Liver Targeting Albumin-Coated Silybin-Phospholipid Particles Prepared by Nab™ Technology for Improving Treatment Effect of Acute Liver Damage in Intravenous Administration.

MLA

Lu, Cong, et al. “Liver Targeting Albumin-Coated Silybin-Phospholipid Particles Prepared by Nab™ Technology for Improving Treatment Effect of Acute Liver Damage in Intravenous Administration.” AAPS PharmSciTech, vol. 20, no. 7, Aug. 2019, p. 293. EBSCOhost, https://doi.org/10.1208/s12249-019-1504-y.

APA

Lu, C., Li, X., Liang, X., Zhang, X., Yin, T., Gou, J., He, H., Zhang, Y., & Tang, X. (2019). Liver Targeting Albumin-Coated Silybin-Phospholipid Particles Prepared by Nab™ Technology for Improving Treatment Effect of Acute Liver Damage in Intravenous Administration. AAPS PharmSciTech, 20(7), 293. https://doi.org/10.1208/s12249-019-1504-y

Chicago

Lu, Cong, Xin Li, Xue Liang, Xinyu Zhang, Tian Yin, Jingxin Gou, Haibing He, Yu Zhang, and Xing Tang. 2019. “Liver Targeting Albumin-Coated Silybin-Phospholipid Particles Prepared by Nab™ Technology for Improving Treatment Effect of Acute Liver Damage in Intravenous Administration.” AAPS PharmSciTech 20 (7): 293. doi:10.1208/s12249-019-1504-y.